CANbridge Pharmaceuticals Inc.'s total assets for Q2 2025 were ¥105.50M, a decrease of 0.00% from the previous quarter. HK:1228 total liabilities were ¥514.58M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.